NMDA Receptor Modulation for the Treatment of Bipolar I Disorder

NCT05977023 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: NMDAE
DRUG: Placebo Cap

Sponsor

China Medical University Hospital

Collaborators

[object Object]